Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 6,179 shares at $82.93 ($512K) on 2026-01-30, disclosed to the SEC on 2026-02-02.
Seasonal sale ($512k) by EVP Research — this insider has traded IONS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |
| IONS | SELL | 2025-10-16 | $4K | — | Filing → |